Page last updated: 2024-10-31

metoprolol and Paranasal Sinus Diseases

metoprolol has been researched along with Paranasal Sinus Diseases in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nair, S1
Collins, M1
Hung, P1
Rees, G1
Close, D1
Wormald, PJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
15-Degree Reverse Trendelenburg Position for FESS[NCT01442740]64 participants (Actual)Interventional2011-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for metoprolol and Paranasal Sinus Diseases

ArticleYear
The effect of beta-blocker premedication on the surgical field during endoscopic sinus surgery.
    The Laryngoscope, 2004, Volume: 114, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Double-Blind Method; Endoscopy; Female; Hem

2004